These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 34656181)

  • 41. Management of BNT162b2 mRNA COVID-19 vaccine in children aged 5-11 years with allergies, asthma, and immunodeficiency: consensus of the Italian Society of Pediatric Allergy and Immunology (SIAIP).
    Novembre E; Tosca M; Caffarelli C; Calvani M; Cardinale F; Castagnoli R; Chiappini E; Cravidi C; Del Giudice MM; Duse M; Licari A; Manti S; Martelli A; Ricci G; Pingitore G; Marseglia GL
    Ital J Pediatr; 2022 May; 48(1):76. PubMed ID: 35578294
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cutaneous reactions after SARS-CoV-2 vaccination: a cross-sectional Spanish nationwide study of 405 cases.
    Català A; Muñoz-Santos C; Galván-Casas C; Roncero Riesco M; Revilla Nebreda D; Solá-Truyols A; Giavedoni P; Llamas-Velasco M; González-Cruz C; Cubiró X; Ruíz-Villaverde R; Gómez-Armayones S; Gil Mateo MP; Pesqué D; Marcantonio O; Fernández-Nieto D; Romaní J; Iglesias Pena N; Carnero Gonzalez L; Tercedor-Sanchez J; Carretero G; Masat-Ticó T; Rodríguez-Jiménez P; Gimenez-Arnau AM; Utrera-Busquets M; Vargas Laguna E; Angulo Menéndez AG; San Juan Lasser E; Iglesias-Sancho M; Alonso Naranjo L; Hiltun I; Cutillas Marco E; Polimon Olabarrieta I; Marinero Escobedo S; García-Navarro X; Calderón Gutiérrez MJ; Baeza-Hernández G; Bou Camps L; Toledo-Pastrana T; Guilabert A
    Br J Dermatol; 2022 Jan; 186(1):142-152. PubMed ID: 34254291
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Case Report of Prolonged Anaphylaxis after COVID-19 Vaccine.
    Armstrong L; Maguire N
    Clin Pract Cases Emerg Med; 2022 Feb; 6(1):21-24. PubMed ID: 35226841
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of Self-reported High-Risk Allergy History With Allergy Symptoms After COVID-19 Vaccination.
    Li L; Robinson LB; Patel R; Landman AB; Fu X; Shenoy ES; Hashimoto DM; Banerji A; Wickner PG; Samarakoon U; Mancini CM; Zhang Y; Blumenthal KG
    JAMA Netw Open; 2021 Oct; 4(10):e2131034. PubMed ID: 34698847
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Successful Desensitization to mRNA COVID-19 Vaccine in a Case Series of Patients With a History of Anaphylaxis to the First Vaccine Dose.
    AlMuhizi F; Ton-Leclerc S; Fein M; Tsoukas C; Garvey LH; Lee D; Ben-Shoshan M; Isabwe GAC; Copaescu AM
    Front Allergy; 2022; 3():825164. PubMed ID: 35386647
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Moderna COVID-19 Vaccine - United States, December 21, 2020-January 10, 2021.
    ;
    MMWR Morb Mortal Wkly Rep; 2021 Jan; 70(4):125-129. PubMed ID: 33507892
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Curbing COVID-19 Vaccine Hesitancy from a Dermatological Standpoint: Analysis of Cutaneous Reactions in the Vaccine Adverse Event Reporting System (VAERS) Database.
    Falotico JM; Desai AD; Shah A; Ricardo JW; Lipner SR
    Am J Clin Dermatol; 2022 Sep; 23(5):729-737. PubMed ID: 35931925
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Side effects of Pfizer/BioNTech (BNT162b2) COVID-19 vaccine reported by the Birzeit University community.
    Abukhalil AD; Shatat SS; Abushehadeh RR; Al-Shami N; Naseef HA; Rabba A
    BMC Infect Dis; 2023 Jan; 23(1):5. PubMed ID: 36604613
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biphasic anaphylaxis after exposure to the first dose of Pfizer-BioNTech COVID-19 mRNA vaccine.
    Abi Zeid Daou C; Natout MA; El Hadi N
    J Med Virol; 2021 Oct; 93(10):6027-6029. PubMed ID: 34050949
    [TBL] [Abstract][Full Text] [Related]  

  • 50. SARS-CoV-2 infection after COVID-19 vaccinations among vaccinated individuals, prevention rate of COVID-19 vaccination: A systematic review and meta-analysis.
    Dinagde DD; Degefa BD; Kitil GW; Feyisa GT; Marami SN
    Heliyon; 2024 May; 10(9):e30609. PubMed ID: 38737290
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Analysis of COVID-19 Incidence and Severity Among Adults Vaccinated With 2-Dose mRNA COVID-19 or Inactivated SARS-CoV-2 Vaccines With and Without Boosters in Singapore.
    Ng OT; Marimuthu K; Lim N; Lim ZQ; Thevasagayam NM; Koh V; Chiew CJ; Ma S; Koh M; Low PY; Tan SB; Ho J; Maurer-Stroh S; Lee VJM; Leo YS; Tan KB; Cook AR; Tan CC
    JAMA Netw Open; 2022 Aug; 5(8):e2228900. PubMed ID: 36018588
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anaphylaxis to SARS-CoV-2 Vaccines in the Setting of a Nationwide Passive Epidemiological Surveillance Program.
    Toledo-Salinas C; Scheffler-Mendoza SC; Castano-Jaramillo LM; Ortega-Martell JA; Del Rio-Navarro BE; Santibáñez-Copado AM; Díaz-Ortega JL; Baptista-Rosas R; Sánchez-Novoa P; García-Grimshaw M; Valdés-Ferrer SI; Reyes-Terán G; Mendoza-Hernández DA
    J Clin Immunol; 2022 Nov; 42(8):1593-1599. PubMed ID: 35976470
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Safety Profile of COVID-19 Vaccines among Healthcare Workers in Poland.
    Paczkowska A; Hoffmann K; Michalak M; Hans-Wytrychowska A; Bryl W; Kopciuch D; Zaprutko T; Ratajczak P; Nowakowska E; Kus K
    Vaccines (Basel); 2022 Mar; 10(3):. PubMed ID: 35335066
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Incidence of immediate allergic reactions to mRNA COVID-19 vaccines in adults with drug allergies and other allergic disorders.
    Marković I; Božan M; Perković T; Paušek K; Nedeljković V; Perković M; Kelava T; Artuković M; Stipić Marković A
    Medicine (Baltimore); 2022 Jul; 101(30):e29571. PubMed ID: 35905225
    [TBL] [Abstract][Full Text] [Related]  

  • 55. COVID-19 mRNA vaccine allergy.
    Risma KA
    Curr Opin Pediatr; 2021 Dec; 33(6):610-617. PubMed ID: 34670264
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Incidence and Risk Factors of Immediate Hypersensitivity Reactions and Immunization Stress-Related Responses With COVID-19 mRNA Vaccine.
    Imai K; Tanaka F; Kawano S; Esaki K; Arakawa J; Nishiyama T; Seno S; Hatanaka K; Sugiura T; Kodama Y; Yamada S; Iwamoto S; Takeshima S; Abe N; Kamae C; Aono S; Ito T; Yamamoto T; Mizuguchi Y
    J Allergy Clin Immunol Pract; 2022 Oct; 10(10):2667-2676.e10. PubMed ID: 35953016
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Allergic Reactions to Current Available COVID-19 Vaccinations: Pathophysiology, Causality, and Therapeutic Considerations.
    Kounis NG; Koniari I; de Gregorio C; Velissaris D; Petalas K; Brinia A; Assimakopoulos SF; Gogos C; Kouni SN; Kounis GN; Calogiuri G; Hung MY
    Vaccines (Basel); 2021 Mar; 9(3):. PubMed ID: 33807579
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Severity of SARS-CoV-2 infection in children with inborn errors of immunity (primary immunodeficiencies): a systematic review.
    Alhumaid S; Al Mutared KM; Al Alawi Z; Sabr Z; Alkhars O; Alabdulqader M; Al Dossary N; ALShakhs FM; Majzoub RA; Alalawi YH; Al Noaim K; Alnaim AA; Al Ghamdi MA; Alahmari AA; Albattat SS; Almubarak YS; Al Abdulmohsen EM; Al Shaikh H; Alobaidan ME; Almusallam HH; Alhassan FM; Alamer MA; Al-Hajji JA; Al-Hajji DA; Alkadi AA; Al Mutair A; Rabaan AA
    Allergy Asthma Clin Immunol; 2023 Aug; 19(1):69. PubMed ID: 37559153
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Attention all anti-vaccinators: The cutaneous adverse events from the mRNA COVID-19 vaccines are not an excuse to avoid them!
    Gronbeck C; Grant-Kels JM
    Clin Dermatol; 2021; 39(4):674-687. PubMed ID: 34809772
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.